OBJECTIVE: To examine how persons move back and forth along levels of mobility disability. DESIGN: Self-reported mobility limitations were used to create categories of annual transition states. The total cost to Medicare associated with each year was calculated for each participant. In addition, we examined cost relative to transition state, adjusting for demographic and other health status variables. SETTING: National survey. PARTICIPANTS: Participants in the longitudinal Medicare Current Beneficiary Survey from 1992 to 2005. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Annual self-reported mobility limitations and total Medi costs. RESULTS: Most participants remained without mobility limitations or improved over time. Reported average costs were 10 times higher for those who transitioned to severe limitations, unable to walk, or death compared with persons who reported no mobility limitation. Estimated costs were highest for those transitioning to increased states of disability and to death. CONCLUSIONS: Mobility limitations in older adults are dynamic, and improvement (as measured by annual transitions) occurred for a large number of Medicare beneficiaries. High total annual costs were observed in groups that transitioned to worsening mobility states, suggesting a link between mobility limitation transitions and cost. Prevention and treatment of mobility limitation may be an important factor to consider in health care reform. Published by Elsevier Inc.
OBJECTIVE: To examine how persons move back and forth along levels of mobility disability. DESIGN: Self-reported mobility limitations were used to create categories of annual transition states. The total cost to Medicare associated with each year was calculated for each participant. In addition, we examined cost relative to transition state, adjusting for demographic and other health status variables. SETTING: National survey. PARTICIPANTS: Participants in the longitudinal Medicare Current Beneficiary Survey from 1992 to 2005. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Annual self-reported mobility limitations and total Medi costs. RESULTS: Most participants remained without mobility limitations or improved over time. Reported average costs were 10 times higher for those who transitioned to severe limitations, unable to walk, or death compared with persons who reported no mobility limitation. Estimated costs were highest for those transitioning to increased states of disability and to death. CONCLUSIONS: Mobility limitations in older adults are dynamic, and improvement (as measured by annual transitions) occurred for a large number of Medicare beneficiaries. High total annual costs were observed in groups that transitioned to worsening mobility states, suggesting a link between mobility limitation transitions and cost. Prevention and treatment of mobility limitation may be an important factor to consider in health care reform. Published by Elsevier Inc.
Authors: Amitabh Jha; Donald L Patrick; Richard F MacLehose; Jason N Doctor; Leighton Chan Journal: Arch Phys Med Rehabil Date: 2002-10 Impact factor: 3.966
Authors: Anne Shumway-Cook; Marcia A Ciol; Kathryn M Yorkston; Jeanne M Hoffman; Leighton Chan Journal: J Am Geriatr Soc Date: 2005-07 Impact factor: 5.562
Authors: L Chan; J N Doctor; R F MacLehose; H Lawson; R A Rosenblatt; L M Baldwin; A Jha Journal: Arch Phys Med Rehabil Date: 1999-06 Impact factor: 3.966
Authors: Jeanne M Hoffman; Anne Shumway-Cook; Kathryn M Yorkston; Marcia A Ciol; Brian J Dudgeon; Leighton Chan Journal: Arch Phys Med Rehabil Date: 2007-05 Impact factor: 3.966
Authors: Martine Extermann; Christiaan Leeuwenburgh; Laila Samiian; Marina Sehovic; Jinze Xu; Christopher Cubitt; Paul B Jacobsen; Marco Pahor; Stephen R Grobmyer; Todd M Manini Journal: J Geriatr Oncol Date: 2016-10-13 Impact factor: 3.599
Authors: Valerie Shuman; Peter C Coyle; Subashan Perera; Jessie M Van Swearingen; Steve M Albert; Jennifer S Brach Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Jennifer S Brach; Subashan Perera; Sandra Gilmore; Jessie M VanSwearingen; Deborah Brodine; David Wert; Neelesh K Nadkarni; Edmund Ricci Journal: Contemp Clin Trials Date: 2016-08-10 Impact factor: 2.226
Authors: Jennifer S Brach; Jessie M VanSwearingen; Alexandra Gil; Neelesh K Nadkarni; Andrea Kriska; Rakie Cham; Subashan Perera Journal: Contemp Clin Trials Date: 2019-12-12 Impact factor: 2.226
Authors: Jennifer S Brach; Subashan Perera; Sandra Gilmore; Jessie M VanSwearingen; Deborah Brodine; Neelesh K Nadkarni; Edmund Ricci Journal: JAMA Intern Med Date: 2017-10-01 Impact factor: 21.873
Authors: Marco Pahor; Jack M Guralnik; Stephen D Anton; Walter T Ambrosius; Steven N Blair; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Nancy W Glynn; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; Jeff D Williamson Journal: J Am Geriatr Soc Date: 2020-02-27 Impact factor: 5.562
Authors: Peter C Coyle; Subashan Perera; Steven M Albert; Janet K Freburger; Jessie M VanSwearingen; Jennifer S Brach Journal: BMC Geriatr Date: 2020-03-16 Impact factor: 3.921